MIRA Pharmaceuticals, Inc. (MIRA)
NASDAQ: MIRA · Real-Time Price · USD
0.9401
+0.0300 (3.30%)
At close: Jul 15, 2026, 4:00 PM EDT
0.9792
+0.0391 (4.16%)
Pre-market: Jul 16, 2026, 8:56 AM EDT
MIRA Pharmaceuticals Market Cap
MIRA Pharmaceuticals has a market cap or net worth of $39.5 million as of July 16, 2026. Its market cap has increased by 38.89% in one year.
Market Cap
39.50M
Enterprise Value
30.10M
1-Year Change
38.89%
Ranking
Category
Stock Price
$0.94
ChartMarket Cap Chart
Since the IPO on August 3, 2023, MIRA Pharmaceuticals's market cap has decreased from $103.22M to $39.50M, a decrease of -61.73%. That is a compound annual growth rate of -27.78%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 15, 2026 | 39.50M | -37.52% |
| Dec 31, 2025 | 63.23M | 234.93% |
| Dec 31, 2024 | 18.88M | 21.65% |
| Dec 29, 2023 | 15.52M | -84.96% |
| Aug 3, 2023 | 103.22M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Pfizer | 138.21B |
| Bristol-Myers Squibb Company | 116.30B |
| Sanofi | 103.69B |
| GSK plc | 102.50B |
| Biogen | 28.34B |
| Grifols | 6.10B |
| Organon & Co. | 3.55B |
| Amarin Corporation | 301.33M |